PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 20240 citationsOpen Access

Supplementary Methods S7 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

View Full Paper
DPDavid J. PinatoADAntonio D’AlessioCFClaudia Angela Maria Fulgenzi

Key Points

Key points are not available for this paper at this time.

Abstract

Supplementary Methods 7. Primary annotations and related number of genes profiled using the NanoString PanCancer Immune panel.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pinato et al. (2024) studied this question.

synapsesocial.com/papers/68e66839b6db6435875f3d63https://doi.org/10.1158/1078-0432.25956598
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supplementary Methods S7 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
  2. 2Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
  3. 3Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
  4. 4Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
  5. 5Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024